Hospital Bacterial Outbreaks
Hospital Superbug Outbreaks: 2026 Investigation & Litigation Updates Active investigations at Vanderbilt, Providence, and UCLA have linked routine procedures to life-threatening infections like CRE, Sepsis, and bloodborne pathogens. While manufacturers are often to blame, 2025-2026 findings suggest hospital cleaning breaches are also at fault. If you contracted a “superbug” or received a notice of exposure after a recent endoscopy, you may have a claim for medical negligence. Learn the signs of hospital-acquired infections and how new 2026 CDC safety mandates may affect your case.
Olympus Endoscope Recalls
Olympus Recall Alert: New January 2026 Warnings & Fatal Infection Risks Beyond the October 2025 “superbug” alerts, Olympus has expanded its 2026 recalls to include fatal component failures in ViziShot needles and high-risk insufflation units. With the FDA now blocking 58 models from U.S. entry, patients who suffered sepsis or injury after a 2024–2025 procedure may have a critical claim. Learn about the new 10X magnification standards and why the 2026 recall expansions are being called a “systemic failure” by legal experts.
Olympus Duodenoscope Infection Lawsuits
Olympus Duodenoscope Infections: October 2025 Safety Alert & Lawsuit Update A critical October 2025 safety notice has linked Olympus TJF-series duodenoscopes to ongoing “superbug” outbreaks and sepsis. Despite following sterilization protocols, patients are contracting drug-resistant infections due to a design defect in the device’s elevator mechanism. If you underwent an ERCP procedure and suffered a severe infection or organ failure, you may be eligible for the 2026 wave of litigation.
Suboxone Films and Dental Decay
Suboxone Tooth Decay: 2026 Lawsuit & Eligibility Updates Recent lawsuits allege Suboxone films cause catastrophic dental decay due to high acidity. If you used name-brand Suboxone films for 6+ months before 2022 and suffered broken teeth or extractions, you may be entitled to compensation for restorative surgery and pain. Learn the 2026 criteria for filing a claim and how to protect your legal rights before upcoming deadlines.
Oxbryta Lawsuit
Treatment Risks and the 2024 Global Recall Pfizer’s Oxbryta (Voxelotor) was marketed as a breakthrough for Sickle Cell Disease, but a 2024 global withdrawal has sparked a wave of legal claims. New clinical data reveals a “devastating paradox”: the drug may actually increase the frequency of life-threatening Vaso-Occlusive Crises (VOCs) and death. If you or a loved one suffered a stroke, organ failure, or severe pain crises while taking Oxbryta, you may be eligible for compensation. Learn about the current 2026 litigation updates and your legal rights in this growing pharmaceutical liability case.
Catheter Fractures & Infections: Identifying the Risks of Bard PowerPorts
Recent lawsuits allege that the Bard PowerPort contains a design flaw—specifically in its Chronoflex tubing—that causes the device to become brittle, crack, or fracture. These defects can lead to life-threatening complications like sepsis, migration, and blood clots. If you received a PowerPort for chemotherapy after 2015 and suffered a serious injury, you may be entitled to compensation. Learn the four warning signs of port failure and how to identify if your device is part of the ongoing litigation.
Spinal Cord Stimulator Lawsuit
Spinal Cord Stimulators promised chronic pain relief but have left thousands with permanent injuries, including loss of bowel control and paralysis. If you required revision surgery for a device from Medtronic, Abbott, or Boston Scientific, you may be entitled to a settlement. Discover your legal options and get a free case review today.
Cartiva Toe Implant Lawsuit
Stay updated on the Cartiva Toe Implant lawsuit as the JPML moves to consolidate cases in 2026. With failure rates reported as high as 64% and a 2024 FDA recall in place, patients suffering from implant subsidence or seeking revision surgery may be eligible for compensation. Learn about the current case status and your legal rights.
